Want to see VMD full AI Analyst Report?
Viemed Healthcare (VMD) Ratios
Viemed Healthcare Ratios
VMD's free cash flow for Q2 2026 was $7.44M. For the 2026 fiscal year, VMD's free cash flow was decreased by $-8.46M and operating cash flow was $15.90M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.18 | 1.42 | 1.19 | 2.11 | 2.66 |
| Quick Ratio | 1.06 | 1.30 | 1.05 | 1.92 | 2.52 |
| Cash Ratio | 0.33 | 0.47 | 0.40 | 0.90 | 1.59 |
| Solvency Ratio | 0.61 | 0.84 | 0.78 | 1.10 | 0.88 |
| Operating Cash Flow Ratio | 1.26 | 1.05 | 1.41 | 1.47 | 1.26 |
| Short-Term Operating Cash Flow Coverage | 47.63 | 95.57 | 42.18 | 0.00 | 15.20 |
| Net Current Asset Value | $ -22.93M | $ 9.11M | $ -2.63M | $ 19.79M | $ 24.17M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.04 | 0.07 | 0.01 | 0.06 |
| Debt-to-Equity Ratio | 0.11 | 0.05 | 0.09 | 0.01 | 0.07 |
| Debt-to-Capital Ratio | 0.10 | 0.05 | 0.08 | 0.01 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.07 | 0.03 | 0.05 | 0.00 | 0.04 |
| Financial Leverage Ratio | 1.52 | 1.35 | 1.36 | 1.21 | 1.24 |
| Debt Service Coverage Ratio | 19.88 | 31.69 | 21.74 | 111.92 | 11.54 |
| Interest Coverage Ratio | 17.52 | 23.07 | 33.80 | 41.89 | 36.42 |
| Debt to Market Cap | 0.04 | 0.01 | 0.02 | 0.00 | 0.03 |
| Interest Debt Per Share | 0.44 | 0.20 | 0.28 | 0.02 | 0.17 |
| Net Debt to EBITDA | 0.05 | -0.25 | -0.07 | -0.65 | -0.91 |
| Profitability Margins | |||||
| Gross Profit Margin | 57.52% | 59.40% | 61.63% | 60.99% | 62.71% |
| EBIT Margin | 8.49% | 7.56% | 8.10% | 6.62% | 10.95% |
| EBITDA Margin | 19.08% | 18.87% | 20.04% | 17.88% | 20.62% |
| Operating Profit Margin | 7.66% | 7.98% | 7.83% | 5.94% | 9.89% |
| Pretax Profit Margin | 8.05% | 7.21% | 7.86% | 6.48% | 10.68% |
| Net Profit Margin | 5.53% | 5.02% | 5.60% | 4.48% | 7.80% |
| Continuous Operations Profit Margin | 5.69% | 5.09% | 5.60% | 4.48% | 7.80% |
| Net Income Per EBT | 68.61% | 69.67% | 71.18% | 69.21% | 72.99% |
| EBT Per EBIT | 105.10% | 90.34% | 100.43% | 108.94% | 107.97% |
| Return on Assets (ROA) | 6.95% | 6.36% | 6.61% | 5.32% | 7.74% |
| Return on Equity (ROE) | 10.55% | 8.57% | 8.99% | 6.41% | 9.62% |
| Return on Capital Employed (ROCE) | 11.91% | 12.81% | 11.67% | 8.40% | 11.56% |
| Return on Invested Capital (ROIC) | 8.30% | 8.96% | 8.17% | 5.79% | 8.28% |
| Return on Tangible Assets | 9.65% | 7.86% | 8.22% | 5.32% | 7.74% |
| Earnings Yield | 5.17% | 3.62% | 3.40% | 2.13% | 4.43% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.56 | 9.00 | 9.92 | 9.01 | 7.95 |
| Payables Turnover | 9.31 | 9.75 | 9.48 | 11.04 | 8.31 |
| Inventory Turnover | 22.75 | 21.08 | 15.17 | 15.15 | 17.77 |
| Fixed Asset Turnover | 3.28 | 2.83 | 2.38 | 2.03 | 1.86 |
| Asset Turnover | 1.26 | 1.27 | 1.18 | 1.19 | 0.99 |
| Working Capital Turnover Ratio | 23.51 | 20.58 | 13.49 | 5.51 | 4.36 |
| Cash Conversion Cycle | 11.41 | 20.43 | 22.34 | 31.54 | 22.53 |
| Days of Sales Outstanding | 34.55 | 40.55 | 36.80 | 40.50 | 45.88 |
| Days of Inventory Outstanding | 16.04 | 17.32 | 24.05 | 24.09 | 20.54 |
| Days of Payables Outstanding | 39.19 | 37.43 | 38.51 | 33.05 | 43.90 |
| Operating Cycle | 50.60 | 57.86 | 60.85 | 64.59 | 66.43 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.33 | 1.01 | 1.18 | 0.72 | 0.57 |
| Free Cash Flow Per Share | 0.31 | 0.03 | 0.50 | 0.13 | 0.07 |
| Dividend Paid and CapEx Coverage Ratio | 1.30 | 1.03 | 1.73 | 1.21 | 1.14 |
| Capital Expenditure Coverage Ratio | 1.30 | 1.03 | 1.73 | 1.21 | 1.14 |
| Operating Cash Flow Coverage Ratio | 3.26 | 5.69 | 4.38 | 39.98 | 3.45 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.17 | 0.25 | 0.20 | 0.19 |
| Free Cash Flow Yield | 4.13% | 0.42% | 6.35% | 1.66% | 1.33% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.55 | 27.66 | 29.39 | 46.97 | 22.59 |
| Price-to-Sales (P/S) Ratio | 1.07 | 1.39 | 1.65 | 2.10 | 1.76 |
| Price-to-Book (P/B) Ratio | 2.04 | 2.37 | 2.64 | 3.01 | 2.17 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 24.22 | 235.82 | 15.75 | 60.25 | 74.93 |
| Price-to-Operating Cash Flow Ratio | 5.57 | 7.95 | 6.66 | 10.53 | 9.16 |
| Price-to-Earnings Growth (PEG) Ratio | 0.63 | 3.73 | 0.37 | -1.35 | -0.31 |
| Enterprise Value Multiple | 5.65 | 7.09 | 8.14 | 11.12 | 7.63 |
| Enterprise Value | 291.44M | 300.14M | 298.56M | 276.01M | 184.25M |
| EV to EBITDA | 5.65 | 7.09 | 8.14 | 11.12 | 7.63 |
| EV to Sales | 1.08 | 1.34 | 1.63 | 1.99 | 1.57 |
| EV to Free Cash Flow | 24.43 | 227.72 | 15.62 | 56.91 | 66.98 |
| EV to Operating Cash Flow | 5.61 | 7.68 | 6.60 | 9.95 | 8.19 |
| Tangible Book Value Per Share | 2.14 | 2.57 | 2.18 | 2.51 | 2.40 |
| Shareholders’ Equity Per Share | 3.64 | 3.39 | 2.97 | 2.51 | 2.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.29 | 0.29 | 0.29 | 0.31 | 0.27 |
| Revenue Per Share | 6.95 | 5.79 | 4.77 | 3.59 | 2.96 |
| Net Income Per Share | 0.38 | 0.29 | 0.27 | 0.16 | 0.23 |
| Tax Burden | 0.69 | 0.70 | 0.71 | 0.69 | 0.73 |
| Interest Burden | 0.95 | 0.95 | 0.97 | 0.98 | 0.98 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| SG&A to Revenue | 0.48 | 0.50 | 0.51 | 0.53 | 0.51 |
| Stock-Based Compensation to Revenue | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 |
| Income Quality | 3.48 | 3.43 | 4.41 | 4.46 | 2.46 |
Currency in USD
